gut microbiota

Developing a donor-based microbiome therapeutic product

Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, talks about the donor-based microbiome therapeutic products research and development.

Incredibly diverse bacteria inhabit the guts of hunter-gatherers in Tanzania

The findings of a recent study provide insights into how industrialized lifestyles have influenced the composition of the human gut microbiota.

Five bacterial signatures define the healthy human gut microbiota

The findings of a recent study may help researchers to characterize the composition of the human gut microbiota in health and disease.

MaaT Pharma Announces European Medicines Agency Granted MaaT033 Orphan Drug Designation Aiming to Improve Overall Survival in Patients Undergoing Hematopoietic Stem Cell transplantation

MaaT033 (capsule), which is being developed as an adjunctive and maintenance therapy to improve overall survival in allo-HSCT, has received orphan drug designation (ODD) status from the European Medicines Agency…

NORDBIOTIC probiotic strains and IBS: the positive effects on adults

New Study Demonstrates Positive Effects of NORDBIOTIC Probiotic Strains on Irritable Bowel Syndrome (IBS) in Adult Patient.

Enabling open science by open source solutions: FAIR data and expert consulting

Elisa Cirillo, team lead research data manager at The Hyve, talks about the importance of having high quality data and strong tools to improve the microbiome research and business.

Microbiota transplant may alleviate intestinal side effects of cancer immunotherapy

The findings of a recent study suggest that FMT is an effective strategy to mitigate the intestinal side effects of cancer immunotherapy.

Gut microbiota may be linked to Alzheimer’s disease risk, clinical study finds

Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.

IBD, Jeroen Raes: ‘We need to treat both the patient and the gut microbiota’

Jeroen Raes, from KU Leuven, Belgium, talks about the design of clinical trials for IBD patient with microbiome based therapies.

Future prospective of FMT in IBD treatment

Lihi Godny, from Rabin Medical Center in Israel, talks about the next steps research has to focus in to improve the FMT efficacy for IBD patients.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top